NORLASE ApS - CVR: 35644547

2022, DKK

11.07.2023

Bruttoresultat

-4.756'

Primær drift

-37.715'

Årets resultat

-32.719'

Aktiver

39.913'

Kortfristede aktiver

26.234'

Egenkapital

15.487'

Afkastningsgrad

-94 %

Soliditetsgrad

39 %

Likviditetsgrad

375 %

Resultat

11.07.2023

Årsrapport	2022 11.07.2023	2021 06.07.2022	2020 22.06.2021	2019 31.07.2020	2018 06.06.2019	2017 29.05.2018	2016 11.05.2017	2015 16.03.2016
Nettoomsætning
Bruttoresultat	-4.755.562	-11.282.020	-13.995.469	-5.531.190	-2.560.540	4.465.429	300.293	-373.916
Resultat af primær drift	-37.714.777	-26.143.987	-28.334.137	-15.200.738	-8.857.453	-906.065	-2.506.535	-2.347.985
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0	0
Finansielle indtægter	4.004.059	989.016	24.243	12.841	28.895	16.642	3.608	666
Finansieringsomkostninger	0	-897.643	-160.240	-63.691	-55.919	-273.971	-56.700	-47.706
Andre finansielle omkostninger	-1.491.473	0	0	0	0	0	0	0
Resultat før skat	-35.202.191	-26.052.614	-28.470.134	-15.251.588	-8.884.477	-1.163.394	-2.559.627	-2.395.025
Resultat	-32.719.162	-24.239.721	-26.264.904	-13.554.309	-7.014.789	-918.364	-1.845.857	-1.987.381
Forslag til udbytte	0	0	0	0	0	0	0	0

Aktiver

11.07.2023

Årsrapport	2022 11.07.2023	2021 06.07.2022	2020 22.06.2021	2019 31.07.2020	2018 06.06.2019	2017 29.05.2018	2016 11.05.2017	2015 16.03.2016
Kortfristede varebeholdninger	11.523.651	6.074.486	4.818.531	2.609.388	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	5.746.204	10.719.202	6.507.618	2.956.375	7.816.490	2.947.910	7.238.782	2.362.048
Likvider	8.963.646	52.967.512	14.317.965	4.630.704	6.681.340	2.876.469	3.008.413	261.631
Kortfristede aktiver	26.233.501	0	0	0	14.497.830	5.824.379	10.247.195	2.623.679
Immaterielle aktiver og goodwill	11.286.494	0	0	0	0	0	0	0
Finansielle anlægsaktiver	749.337	575.742	575.742	702.889	60.696	26.302	79.534	62.592
Materielle aktiver	1.643.391	38.628	80.033	121.185	32.712	41.291	97.629	154.122
Langfristede aktiver	13.679.222	614.370	655.775	824.074	93.408	67.593	177.163	216.714
Aktiver	39.912.723	70.375.570	26.299.889	11.020.541	14.591.238	5.891.972	10.424.358	2.840.393

Aktiver

11.07.2023

Passiver

11.07.2023

Årsrapport	2022 11.07.2023	2021 06.07.2022	2020 22.06.2021	2019 31.07.2020	2018 06.06.2019	2017 29.05.2018	2016 11.05.2017	2015 16.03.2016
Forslag til udbytte	0	0	0	0	0	0	0	0
Egenkapital	15.487.306	48.206.468	6.551.127	9.269.451	12.597.866	3.760.911	4.679.275	1.910.984
Hensatte forpligtelser	0	0	0	0	89.400	660.915	1.389.083	0
Langfristet gæld til banker	0	0	0	0	0	0	0	0
Anden langfristet gæld	0	15.684.635	16.360.493	397.073	0	0	0	0
Leverandører af varer og tjenesteydelser	1.578.518	2.546.716	1.924.101	397.601	644.333	305.824	463.918	140.877
Kortfristede forpligtelser	6.991.304	6.484.467	3.388.269	1.354.017	1.675.784	1.151.067	3.856.000	429.409
Gældsforpligtelser	24.425.417	22.169.102	19.748.762	1.751.090	1.903.972	1.470.146	4.356.000	929.409
Forpligtelser	24.425.417	22.169.102	19.748.762	1.751.090	1.903.972	1.470.146	4.356.000	929.409
Passiver	39.912.723	70.375.570	26.299.889	11.020.541	14.591.238	5.891.972	10.424.358	2.840.393

Passiver

11.07.2023

Nøgletal

11.07.2023

Årsrapport	2022 11.07.2023	2021 06.07.2022	2020 22.06.2021	2019 31.07.2020	2018 06.06.2019	2017 29.05.2018	2016 11.05.2017	2015 16.03.2016
Afkastningsgrad	-94,5 %	-37,1 %	-107,7 %	-137,9 %	-60,7 %	-15,4 %	-24,0 %	-82,7 %
Dækningsgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-211,3 %	-50,3 %	-400,9 %	-146,2 %	-55,7 %	-24,4 %	-39,4 %	-104,0 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	Na.	-2.912,5 %	-17.682,3 %	-23.866,4 %	-15.839,8 %	-330,7 %	-4.420,7 %	-4.921,8 %
Soliditestgrad	38,8 %	68,5 %	24,9 %	84,1 %	86,3 %	63,8 %	44,9 %	67,3 %
Likviditetsgrad	375,2 %	Na.	Na.	Na.	865,1 %	506,0 %	265,7 %	611,0 %

Resultat

11.07.2023

Gæld

11.07.2023

Årsrapport

11.07.2023

Nyeste:01.01.2022- 31.12.2022(offentliggjort: 11.07.2023)

Information om virksomhedens regnskabsklasse:This annual report has been presented in accordance with the provisions of the Danish Financial Statements Act governing reporting class B enterprises with addition of a few provisions for reporting class C. The accounting policies applied to these financial statements are consistent with those applied last year.

Oplysning om pantsætninger og sikkerhedsstillelser:16 Assets charged and collateralThere are no assets charged and collateral.

Oplysning om eventualaktiver:14 Contingent assetsThe company has a deferred tax asset that amounts to DKK 3,702 thousand which has not been capitalized due to the uncertainty of when the company is able to use it.

Beretning

11.07.2023

Dato for ledelsens godkendelse af årsrapporten:2023-06-26

Beskrivelse af usikkerhed ved indregning eller måling:Uncertainty relating to recognition and measurementAs the Company is a development company, there is a natural uncertainty associated with the measurement of the Company’s development activities and future earnings. At 31 December 2022, the Company has recognised DKK 2,854 thousand regarding ongoing development projects and DKK 8,432 thousand regarding completed developments projects. The value of the development projects depends on the Company’s ability to develop, market and attracting enough customers, who through the sale of the systemes generate positive earnings that could yield the total investment. Accordingly, Management has deemed the valuation sound. If the Company’s sales and growth deviate significantly from the current plans, there may be uncertainty associated with the valuation.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:The Board of Directors and the Executive Board have today considered and approved the annual report of Norlase ApS for the financial year 01. 01. 2022 - 31. 12. 2022.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Primary activitiesThe Company's principal activity is based on commercializing high-tech medical products and services based on laser technology, as well as any other activity the Board finds related. This year’s results come to a loss of DKK 32,719 thousand. Management considers the performance in line with expectations given that the Company is still at a stage of development. Equity is DKK 15,487 thousand at the balance sheet date. The key activities of the year were to continue the global market roll-out of the company’s existing products, and to advance the development of new products. The results of the year showed a significant growth in sales compared to the previous year, which was in line with expectations. The company continued to invest heavily in the development of new products and technology during the year. Based on these efforts, the company expects to launch several important products in the coming years, including a high-end product for which sales are expected to begin in early 2023. The company also obtained key regulatory approvals for its existing products during the year. During the year, the company signed an investment agreement for new equity financing of more than DKK 50 million, to be completed in early 2023. Based on these developments, Management's assessment is that the company is in a solid economic position, with a strong growth trajectory secure financing.